Mobile-health Network Solutions Research and Development Expenses 1970-1969 | MNDR
Mobile-health Network Solutions research and development expenses from 1970 to 1969. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Mobile-health Network Solutions Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| Mobile-health Network Solutions Quarterly Research and Development Expenses (Millions of US $) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.049B | $0.000B |
| Mobile-health Network Solutions is a telehealth solutions provider principally in Singapore. The company offer users with a range of seamless and hassle-free telehealth solutions, which encompasses teleconsultation services, including the issuance of electronic medical certificates and delivery of medications to user homes, as well as other personalized services such as weight management programs. Mobile-health Network Solutions is based in Singapore. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.864B | 19.69 |
| Inspire Medical Systems (INSP) | United States | $4.586B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.375B | 0.00 |
| Axonics (AXNX) | United States | $3.425B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.985B | 0.00 |
| Azenta (AZTA) | United States | $2.746B | 154.39 |
| IRhythm Technologies (IRTC) | United States | $2.741B | 0.00 |
| Enovis (ENOV) | United States | $2.730B | 20.24 |
| 10x Genomics (TXG) | United States | $2.671B | 0.00 |
| Privia Health (PRVA) | United States | $2.059B | 115.07 |
| Schrodinger (SDGR) | United States | $1.583B | 0.00 |
| Omnicell (OMCL) | United States | $1.499B | 51.83 |
| Phreesia (PHR) | United States | $1.221B | 0.00 |
| Standard BioTools (LAB) | United States | $0.947B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.639B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.625B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.566B | 0.00 |
| Talkspace (TALK) | United States | $0.455B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.384B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.331B | 0.00 |
| Pulmonx (LUNG) | United States | $0.283B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.211B | 0.00 |
| Outset Medical (OM) | United States | $0.183B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.154B | 0.00 |
| TruBridge (TBRG) | United States | $0.139B | 7.49 |
| American Well (AMWL) | United States | $0.119B | 0.00 |
| 111 (YI) | China | $0.105B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.096B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.074B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.060B | 0.00 |
| Augmedix (AUGX) | United States | $0.049B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Zepp Health (ZEPP) | China | $0.044B | 0.00 |
| Movano (MOVE) | United States | $0.037B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.025B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Cue Health (HLTH) | United States | $0.012B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |